NCT01780077View on ClinicalTrials.gov

Evaluation of Safety, PK, and Preliminary Effects on Scar Formation of Multiple Intradermal Administrations of RXI-109

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

June 30, 2014

Study Completion Date

November 30, 2014

Conditions
CicatrixScar Prevention
Interventions
DRUG

RXI-109

Multiple intradermal injections of RXI-109 at incision sites

DRUG

Placebo

Multiple intradermal injections of placebo at incision sites

All Listed Sponsors
lead

RXi Pharmaceuticals, Corp.

INDUSTRY

NCT01780077 - Evaluation of Safety, PK, and Preliminary Effects on Scar Formation of Multiple Intradermal Administrations of RXI-109 | Biotech Hunter | Biotech Hunter